Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pembrolizumab-induced agranulocytosis.
J Oncol Pharm Pract. 2024 Jan 30:10781552241228774. doi: 10.1177/10781552241228774. Online ahead of print.
J Oncol Pharm Pract. 2024.
PMID: 38291678
Severe hepatotoxicity during treatment with capmatinib.
Valencia Soto CM, Martínez Callejo V, García-Avello Fernández-Cueto A, Villacañas Palomares MV, Barbadillo Villanueva S, Ochagavía Sufrategui M, López-Brea Piqueras MF, Valero Domínguez M.
Valencia Soto CM, et al. Among authors: garcia avello fernandez cueto a.
J Oncol Pharm Pract. 2023 Sep;29(6):1484-1488. doi: 10.1177/10781552231173120. Epub 2023 May 8.
J Oncol Pharm Pract. 2023.
PMID: 37157816
Item in Clipboard
Predictive value of immune-related adverse events during pembrolizumab treatment in non-small cell lung cancer.
Valencia Soto CM, Villacañas Palomares MV, Garcia-Avello Fernández-Cueto A, Barbadillo Villanueva S, Martínez Callejo V, Ochagavía Sufrategui M, Muñoz Cacho P, Valero Domínguez M.
Valencia Soto CM, et al. Among authors: garcia avello fernandez cueto a.
Eur J Hosp Pharm. 2023 Dec 27;31(1):40-45. doi: 10.1136/ejhpharm-2021-003038.
Eur J Hosp Pharm. 2023.
PMID: 35383033
Free PMC article.
Item in Clipboard
Cite
Cite